News
🇪🇺 EMALatest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 1–12 of 341 articles
Quick answer
NovaPharmaNews Europe & United Kingdom news feed tracks 341 published stories — EMA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
EU Pharma Package exclusivity timelines: what innovators can do now
EMA board backs Ebola response, flags 2025 annual report at June meeting
EMA Tightens Liver Safety Checks for Tavneos After Fatal Cases
FDA approves capivasertib plus abiraterone and prednisone in PTEN-deficient mHSPC
China Becomes Big Pharma's Essential R&D Partner
MHRA targets medicine safety with new AI sandbox
BioCryst’s New ORLADEYO Data Adds Real-World HAE Evidence
EMA researchers map AI research priorities across the medicines lifecycle
Truqap gains US approval in PTEN-deficient metastatic prostate cancer
Duty of care at oncology conferences spotlights planetary health research
Synthetic real-world data reshapes oncology trial decision-making
EMA approved 104 human medicines in 2025: what changed
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.